BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sember AM, LoFaso ME, Lewis SJ. An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy. J Crit Care 2022;69:154011. [PMID: 35202996 DOI: 10.1016/j.jcrc.2022.154011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Honore PM, Redant S, Djimafo P, Preseau T, Cismas BV, Kaefer K, Barreto Gutierrez L, Anane S, Gallerani A, Attou R. Letter to the Editor : "An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy". J Crit Care 2022;70:154058. [PMID: 35561558 DOI: 10.1016/j.jcrc.2022.154058] [Reference Citation Analysis]
2 Sember AM, LoFaso ME, Lewis SJ. Author response: "An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy". J Crit Care 2022;70:154059. [PMID: 35568021 DOI: 10.1016/j.jcrc.2022.154059] [Reference Citation Analysis]